El-ASSAL, M. I. and SAMUEL, D. (2022) “OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS”, International Journal of Pharmacy and Pharmaceutical Sciences, 14(1), pp. 17–27. doi: 10.22159/ijpps.2022v14i1.43145.